Search results for " inflammation."

showing 10 items of 623 documents

Effect of Magnesium Supplementation on Inflammatory Parameters: A Meta-Analysis of Randomized Controlled Trials

2022

Magnesium (Mg) may have several beneficial effects on human health outcomes. One hypothesized mechanism eliciting such effects is the action of Mg on serum inflammatory parameters. However, studies on this topic to date have several important limitations. Therefore, the present systematic review and meta-analysis aimed to summarize the current state of the art of all randomized control trials (RCTs) investigating the effects of Mg supplementation versus placebo on serum parameters of inflammation. We searched several databases until 23rd November 2021 for RCTs. Eligible studies were RCTs investigating the effect of oral Mg supplementation vs. placebo and having serum inflammatory markers as…

magnesium; inflammation; C reactive protein; tumor necrosis factor; randomized controlled trial; meta-analysisNutrition and DieteticsC reactive proteinNutrition. Foods and food supplytumor necrosis factorMiddle Agedmagnesiummeta-analysisinflammationDietary Supplementsrandomized controlled trialHumansTX341-641BiomarkersRandomized Controlled Trials as TopicFood Science
researchProduct

Marker of inlammation and prevalance of vascular disease in patients with metabolic syndrome

2007

markers inflammationvascular diseasemetabolic syndrome
researchProduct

ANMCO/ELAS/SIBioC Consensus Document: Biomarkers in heart failure

2017

Abstract Biomarkers have dramatically impacted the way heart failure (HF) patients are evaluated and managed. A biomarker is a characteristic that is objectively measured and evaluated as an indicator of normal biological or pathogenic processes, or pharmacological responses to a therapeutic intervention. Natriuretic peptides [B-type natriuretic peptide (BNP) and N-terminal proBNP] are the gold standard biomarkers in determining the diagnosis and prognosis of HF, and a natriuretic peptide-guided HF management looks promising. In the last few years, an array of additional biomarkers has emerged, each reflecting different pathophysiological processes in the development and progression of HF: …

medicine.drug_classFibrosiGalectin 3Heart failure030204 cardiovascular system & hematologyBioinformatics03 medical and health sciences0302 clinical medicineFibrosismedicineNatriuretic peptideNatriuretic peptides030212 general & internal medicineBiomarkers; Fibrosis; Galectin 3; Heart failure; Inflammation; Natriuretic peptides; Troponin; Cardiology and Cardiovascular MedicinePathologicalInflammationbiologybusiness.industryArticlesBiomarkermedicine.diseaseBrain natriuretic peptideFibrosisTroponinTroponinGalectin-3Heart failurebiology.proteinBiomarker (medicine)businessCardiology and Cardiovascular MedicineBiomarkers; Fibrosis; Galectin 3; Heart failure; Inflammation; Natriuretic peptides; TroponinBiomarkersNatriuretic peptide
researchProduct

Nutritional Status in Aging and Lung Disease

2016

Abstract Lung diseases exert a negative impact on nutritional status, especially among older patients where aging per se is already associated with relevant changes in nutrient intake, metabolism, and body composition. Both respiratory (increased respiratory work, hypoxia, and local oxidative stress and inflammation) and nonrespiratory (sarcopenia, reduced mitochondrial biogenesis and anabolic hormones, balance of orexigenic/anorexigenic neuropeptides, and systemic inflammation and oxidative stress) contribute to the association between lung diseases and malnutrition. For these reasons, nutritional assessments are of paramount importance in older patients with lung diseases. Current evidenc…

medicine.medical_specialtyAgingPhysiologySettore MED/10 - Malattie Dell'Apparato RespiratorioSystemic inflammationmedicine.disease_causeElderlyOrexigenicInternal medicineVitamin D and neurologyMedicinechemistry.chemical_classificationbusiness.industryMalnutritionHypoxia (medical)medicine.diseaseMalnutritionEndocrinologychemistrySarcopeniaLung diseasemedicine.symptombusinessOxidative stressmedicine.drugPolyunsaturated fatty acid
researchProduct

Fractional exhaled nitric oxide is associated with more severe asthma

2018

Fractional exhaled nitric oxide (FeNO) levels are used as a marker of airway inflammation. The aim of the present work was to evaluate a possible relationship between FeNO and parameters of asthma control and severity in different asthma phenotypes. FeNO was evaluated in 200 asthma patients (37% male, mean age ± SD 54±15 years, 19% controlled (GINA), 30% treated with oral corticosteroids (OCS), median FEV1 (interquartile range) 2,05 L (1,49-2,70), 74% pred. (56-90%)), together with other asthma characteristics (lung function, asthma control, allergies, serum IgE, serum ECP, and blood eosinophils). Patients with poorly controlled asthma had significantly higher FeNO values (ACQ-5≥1.5 vs. 70%…

medicine.medical_specialtyAllergybiologybusiness.industrySevere asthmaAirway inflammationrespiratory systemImmunoglobulin Emedicine.diseaseGastroenterologySerum igerespiratory tract diseases03 medical and health sciences0302 clinical medicine030228 respiratory systemInterquartile rangeInternal medicineExhaled nitric oxidemedicinebiology.protein030212 general & internal medicinebusinessAsthmaMonitoring Airway Disease
researchProduct

Does aspirin save lives in patients with COVID-19?

2021

‘An aspirin a day keeps the heart attack away’, is this also true in the prevention of thrombotic events associated with COVID-19? The rising COVID-19 pandemic has led to much work in the understanding of the pathophysiology of the disease. COVID-19 infection is thought to be an endothelial disease. Supporting this concept, it has been suggested that infection with SARS-CoV-2, the aetiological agent for COVID-19 infection, leads to a state mimicking Virchow’s triad, that is, vascular endothelial injury, blood stasis and clotting in concert with systemic inflammation resulting in systemic thrombosis. In keeping with this concept, moderately and critically ill patients with COVID-19 have been…

medicine.medical_specialtyAspirin2474business.industryCOVID-19healthcareInflammationDiseaseBlood stasisSystemic inflammationmedicine.diseaseThrombosisEditorialmedicineEtiologyPlatelet activationmedicine.symptomCardiology and Cardiovascular MedicineIntensive care medicinebusinessoutcome assessmentmedicine.drugHeart
researchProduct

Expert opinion on managing chronic HCV in patients with cardiovascular disease

2018

International audience; Extrahepatic manifestations of chronic HCV infection include cardiovascular diseases and an increase in cardiovascular mortality. The pathogenic mechanisms by which HCV contributes to cardiovascular disease are not well defined, however, it is likely that systemic inflammation, and the promotion of other metabolic diseases are involved. In this Review, the evidence for HCV infection as a non-traditional risk factor for cardiovascular disease is evaluated. Furthermore, practical advice to evaluate cardiovascular disease risk and disease in chronic hepatitis C patients are included for help in daily clinical practice. Despite the advances in therapies for the treatment…

medicine.medical_specialtyCardiotonic AgentsHepacivirusDisease030204 cardiovascular system & hematologySystemic inflammationAntiviral Agents03 medical and health sciences0302 clinical medicine[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemRisk Factors[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseasesOdds RatioHumansMedicineDrug InteractionsPharmacology (medical)In patient030212 general & internal medicineRisk factorIntensive care medicineExpert TestimonyCardiovascular mortalityInflammationPharmacologybusiness.industryDisease progressionDisease ManagementHepatitis C Chronic3. Good healthInfectious DiseasesCardiovascular DiseasesExpert opinionPractice Guidelines as TopicDisease riskmedicine.symptombusiness
researchProduct

Oral Health Scales: Design of an Oral Health Scale of Infectious Potential

2013

Objectives: In this paper we propose a new Global Oral Health Scale that will allow the infectious potential of the oral cavity, clinically manifest as local and focal infections, to be condensed into a single parameter. Study Design: Based on a number of oral health scales previously designed by our group, we designed a final version that incorporates dental and periodontal variables (some of them evaluated using corroborated objective indices) that reflect the presence of caries and periodontal disease. Results: The application of the proposed oral health scale requires the examination of 6 sites per tooth (mesio- buccal, medio-buccal, disto-buccal, disto-lingual, medio-lingual and mesio-…

medicine.medical_specialtyDentistryOdontologíaOral HealthOral healthOral cavityRisk Assessmentstomatognathic systemPeriodontal diseaseEpidemiologyHumansMedicineGingival inflammationGeneral DentistryFinal versionbusiness.industrySingle parameterBacterial Infections:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludstomatognathic diseasesOtorhinolaryngologyScale (social sciences)UNESCO::CIENCIAS MÉDICASResearch-ArticleOdontostomatology for the Disabled or Special PatientsSurgerybusinessMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Dietary therapy and non-surgical periodontal treatment in obese patients with chronic periodontitis.

2018

Aim The effect of dietary weight loss intervention on periodontal therapy is unknown. Therefore, we aimed to evaluate whether weight loss improves the response of obese subjects to non-surgical periodontal treatment. Materials and methods This interventional study in obese patients was conducted at the University Hospital Dr. Peset (Valencia, Spain). Patients were divided into two groups with and without dietary therapy. All participants received non-surgical periodontal treatment. Periodontal, anthropometric and biochemical parameters were assessed at baseline and 12 weeks. Results A total of 78 patients were re-evaluated after intervention. All periodontal parameters improved in both grou…

medicine.medical_specialtyDiet therapy030209 endocrinology & metabolismSystemic inflammationGastroenterology03 medical and health sciences0302 clinical medicineWeight lossInternal medicinePeriodontal Attachment LossWeight LossMedicineHumansObesityPeriodontitisComplement component 3business.industry030206 dentistryAnthropometrymedicine.diseaseChronic periodontitisObesitySpainChronic PeriodontitisPeriodonticsmedicine.symptomPeriodontal IndexbusinessJournal of clinical periodontology
researchProduct

Takayasu's disease effects on the kidneys: current perspectives.

2018

Takayasu arteritis (TA) is a chronic vasculitis disease of unknown etiology. Clinically significant renal disease is relatively common, and renovascular hypertension is the major renal problem. The assessment of TA activity is usually challenging because vascular inflammation may progress to fixed vascular injury without findings of active disease. Until now, the best therapeutic options have not been identified. This review highlights the current perspectives of renal involvement in TA.

medicine.medical_specialtyDiseaseReview030204 cardiovascular system & hematologyurologic and male genital diseasesRenovascular hypertension03 medical and health sciences0302 clinical medicineLarge vessel vasculitisInternal medicinemedicinearteritiArteritisarteritis; kidney involvement; large vessel vasculitis030203 arthritis & rheumatologybusiness.industryVascular inflammationmedicine.diseasekidney involvementNephrologyCardiologyEtiologyarteritislarge vessel vasculitisTakayasu's diseasebusinessVasculitisInternational journal of nephrology and renovascular disease
researchProduct